Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03826)
Primary Purpose
Allergic Rhinitis
Status
Completed
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
Desloratadine (Clarinex)
Cetirizine (Zyrtec)
Sponsored by
About this trial
This is an interventional other trial for Allergic Rhinitis
Eligibility Criteria
Inclusion Criteria:
Subjects must be:
- Between 6 and 11 years of age in good general health
- Premenarcheal if female
Exclusion Criteria:
Subjects who:
- Have known allergies or sensitivities to either of the drug formulations
- Have a medical condition that may interfere with the subject's ability to discriminate between tastes
- Have used any antihistamines within 24 hours prior to dosing
- Were taking sedatives, tranquilizers, or monoamine oxidase inhibitor drugs
- Were involved in another clinical or market research study within the past 30 days
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Desloratadine and Cetirizine Crossover
Arm Description
To compare the preference in taste between desloratadine and cetirizine.
Outcomes
Primary Outcome Measures
Taste acceptability as determined from smiley-face scale of 1 (frowning child) to 5 (happy child face).
Secondary Outcome Measures
Taste flavor preference between bubble-gum, banana-grape, or grape flavors
Adverse Events
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00794794
Brief Title
Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03826)
Official Title
A Single-Center, Pediatric, Comparative Taste Test of Desloratadine and Cetirizine Antihistamine Syrup Medications
Study Type
Interventional
2. Study Status
Record Verification Date
February 2022
Overall Recruitment Status
Completed
Study Start Date
November 2004 (undefined)
Primary Completion Date
November 2004 (Actual)
Study Completion Date
November 2004 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Organon and Co
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study was conducted to compare the taste acceptability of Zyrtec syrup with desloratadine syrup in children. Children between 6 and 11 years of age received 5 mL of each syrup, separated by 15 to 20 minutes on a single day.
Detailed Description
This study is a cross-over study design.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Allergic Rhinitis
7. Study Design
Primary Purpose
Other
Study Phase
Phase 3
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
204 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Desloratadine and Cetirizine Crossover
Arm Type
Experimental
Arm Description
To compare the preference in taste between desloratadine and cetirizine.
Intervention Type
Drug
Intervention Name(s)
Desloratadine (Clarinex)
Other Intervention Name(s)
SCH 034117, Clarinex
Intervention Description
Each subject received 5 mL of desloratadine syrup one time
Intervention Type
Drug
Intervention Name(s)
Cetirizine (Zyrtec)
Other Intervention Name(s)
Zyrtec
Intervention Description
Each subject received 5 mL of cetirizine syrup
Primary Outcome Measure Information:
Title
Taste acceptability as determined from smiley-face scale of 1 (frowning child) to 5 (happy child face).
Time Frame
During the only study visit
Secondary Outcome Measure Information:
Title
Taste flavor preference between bubble-gum, banana-grape, or grape flavors
Time Frame
During the only study visit
Title
Adverse Events
Time Frame
During the only study visit
10. Eligibility
Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
11 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Subjects must be:
Between 6 and 11 years of age in good general health
Premenarcheal if female
Exclusion Criteria:
Subjects who:
Have known allergies or sensitivities to either of the drug formulations
Have a medical condition that may interfere with the subject's ability to discriminate between tastes
Have used any antihistamines within 24 hours prior to dosing
Were taking sedatives, tranquilizers, or monoamine oxidase inhibitor drugs
Were involved in another clinical or market research study within the past 30 days
12. IPD Sharing Statement
Learn more about this trial
Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03826)
We'll reach out to this number within 24 hrs